Ophir Shalem
- Aging top 0.2%
- Molecular Biology top 0.2%
- CRISPR and Genetic Engineering 20
- RNA and protein synthesis mechanisms 13
- Advanced biosensing and bioanalysis techniques 7
- RNA modifications and cancer 6
- RNA Research and Splicing 6
- Genomics and Chromatin Dynamics 6
- Protein Degradation and Inhibitors 5
- Genetics top 0.5%
- Virus-based gene therapy research 5
- Cancer Research top 2%
- Co-authors
- Feng ZhangNeville E. SanjanaDavid ScottXuebing WuF. Ann RanXi ShiTarjei S. MikkelsenDirk Heckl
- Partner nations
- United StatesIsraelJapan
In The Last Decade
Ophir Shalem
39 papers receiving 12.9k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Aging 815
- Business and International Management 822
- Molecular Biology 11.6k
- Genetics 2.3k
- Cancer Research 745
Countries citing papers authored by Ophir Shalem
This map shows the geographic impact of Ophir Shalem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ophir Shalem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ophir Shalem more than expected).
Fields of papers citing papers by Ophir Shalem
This network shows the impact of papers produced by Ophir Shalem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ophir Shalem. The network helps show where Ophir Shalem may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ophir Shalem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 23 | |
| 10 | 2019 | 77 | |
| 11 | Transcription control by the ENL YEATS domain in acute leukaemia | 2017 | 1 |
| 12 | 2016 | 0 | |
| 13 | Hypoxia as a therapy for mitochondrial disease | 2016 | 1 |
| 14 | BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis | 2015 | 2 |
| 15 | High-throughput functional genomics using CRISPR–Cas9 | 2015 | 26 |
| 16 | High-throughput functional genomics using CRISPR–Cas9breakdown → | 2015 | 871 |
| 17 | Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasisbreakdown → | 2015 | 633 |
| 18 | Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cellsbreakdown → | 2013 | 3656 |
| 19 | DNA targeting specificity of RNA-guided Cas9 nucleasesbreakdown → | 2013 | 3441 |
| 20 | 2011 | 70 |
About Ophir Shalem
Ophir Shalem is a scholar working on Aging, Molecular Biology and Cellular and Molecular Neuroscience, having authored 42 papers that have together received 13.1k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (20 papers), RNA and protein synthesis mechanisms (13 papers), Advanced biosensing and bioanalysis techniques (7 papers), RNA modifications and cancer (6 papers), RNA Research and Splicing (6 papers), Genomics and Chromatin Dynamics (6 papers), Virus-based gene therapy research (5 papers) and Protein Degradation and Inhibitors (5 papers). The work is most often cited by research in Aging (815 citations), Business and International Management (822 citations) and Molecular Biology (11.6k citations). Ophir Shalem has collaborated with scholars based in United States, Israel and Japan. Frequent co-authors include Feng Zhang, Neville E. Sanjana, David Scott, Xuebing Wu, F. Ann Ran, Xi Shi, Tarjei S. Mikkelsen, Dirk Heckl, David E. Root and John G. Doench. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.